Röth, Alexander http://orcid.org/0000-0003-4414-7699
Barcellini, Wilma
Tvedt, Tor Henrik Anderson
Miyakawa, Yoshitaka
Kuter, David J.
Su, Jun
Jiang, Xiaoyu
Hobbs, William
Arias, Jaime Morales
Shafer, Frank
Weitz, Ilene C.
Funding for this research was provided by:
Sanofi
Universitätsklinikum Essen
Article History
Received: 19 November 2021
Accepted: 7 August 2022
First Online: 23 August 2022
Declarations
:
: This study was performed in accordance with the study protocol, the Declaration of Helsinki, and the International Council for Harmonisation guidelines for Good Clinical Practice. All patients provided written informed consent for their participation in the study.
: AR has received research support from Roche, received honoraria, and provided consultancy to Alexion Pharmaceuticals, Inc., Apellis Pharmaceuticals, Novartis, Roche, Bioverativ, a Sanofi company, and Sanofi. WB has received research support from Alexion Pharmaceuticals, Inc., and Novartis; participated in advisory boards for Agios, Alexion Pharmaceuticals, Inc., Bioverativ, and Incyte; and has been an invited speaker for Alexion Pharmaceuticals, Inc., and Novartis. THAT has participated in advisory boards for Alexion Pharmaceuticals, Inc., Novartis, and Ablynx. YM has provided consultancy for Bioverativ and Sanofi. DJK has provided consultancy to Actelion (Syntimmune), Agios, Alnylam, Amgen, Argenx, Bristol-Myers Squibb, Caremark, Daiichi Sankyo, Dova, Kyowa Kirin, Merck Sharp & Dohme, Momenta, Novartis, Pfizer, Platelet Disorder Support Association, Principia, Protalex, Protalix Biotherapeutics, Rigel, Sanofi Genzyme, Shionogi, Shire, Takeda (Bioverativ), UCB, Up-To-Date, and Zafgen; and received research funding from Actelion (Syntimmune), Agios, Alnylam, Amgen, Argenx, Bristol-Myers Squibb, Kezar Life Sciences, Inc., Principia, Protalex, Rigel, and Takeda (Bioverativ). XJ and FS are employees of Sanofi and may hold shares and/or stock options in the company. JS, WH and JMA were employees of Sanofi at the time of the study. ICW has received consultancy and speaker honoraria from Alexion and Apellis.